E. Kaplan, The resurgence of group A streptococcal infections and their sequelae, European Journal of Clinical Microbiology & Infectious Diseases, vol.44, issue.2
DOI : 10.1007/BF01964407

M. Cunningham, Pathogenesis of Group A Streptococcal Infections, Clinical Microbiology Reviews, vol.13, issue.3
DOI : 10.1128/CMR.13.3.470-511.2000

D. Musher, R. Hamill, C. Wright, J. Clarridge, and C. Ashton, Trends in Bacteremic Infection Due to Streptococcus pyogenes (Group A Streptococcus), 1986-1995, Emerging Infectious Diseases, vol.2, issue.1, pp.54-56, 1996.
DOI : 10.3201/eid0201.960107

D. Stevens, M. Tanner, J. Winship, R. Swarts, K. Ries et al., Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin A, New England Journal of Medicine, vol.321, issue.1
DOI : 10.1056/NEJM198907063210101

S. Holm, . Invasive, J. Engl, V. Med-romanus, L. Burman et al., 22 août Invasive group A streptococcal infections--United Kingdom Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study The global burden of group A streptococcal diseases Beachey EH, Ofek I. Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein, From the Centers for Disease Control and Prevention JAMA J Am Med Assoc. 6 juill J Infect Dis. sept Lancet Infect Dis. J Exp Med. 1 avr, vol.3352721645143, issue.813114, pp.590-591, 1976.

R. Lancefield, . Persistence, . Type-specific, . Antibodies, . Man et al., Disponible sur: http://www.uark, J Exp Med. 1 août, vol.14110, issue.2, pp.271-292, 1959.

M. Mora, G. Bensi, S. Capo, F. Falugi, C. Zingaretti et al., Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.15641-15646, 2005.
DOI : 10.1073/pnas.0507808102

K. Todar, . Streptococcus, M. Batzloff, K. Mulholland, and J. Carapetis, Todar's Online Textbook of Bacteriology. [cité 18 mai 2014] Disponible sur: http://textbookofbacteriology.net/streptococcus_2 Group A streptococcal vaccines: facts versus fantasy, Curr Opin Infect Dis. déc, vol.22, issue.6, pp.544-552, 2009.

V. Fischetti, Streptococcal M protein: molecular design and biological behavior., Clinical Microbiology Reviews, vol.2, issue.3, pp.285-314, 1989.
DOI : 10.1128/CMR.2.3.285

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC358122

A. Bisno, M. Brito, and C. Collins, Molecular basis of group A streptococcal virulence, The Lancet Infectious Diseases, vol.3, issue.4, pp.191-200, 2003.
DOI : 10.1016/S1473-3099(03)00576-0

E. Whitnack, A. Bisno, E. Beachey, M. Wessels, A. Moses et al., Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci, Infect Immun. mars Proc Natl Acad Sci U S A. 1 oct, vol.3188, issue.21, pp.985-9918317, 1981.

D. Johnson, D. Stevens, and E. Kaplan, Epidemiologic Analysis of Group A Streptococcal Serotypes Associated with Severe Systemic Infections, Rheumatic Fever, or Uncomplicated Pharyngitis, Journal of Infectious Diseases, vol.166, issue.2, pp.374-382, 1992.
DOI : 10.1093/infdis/166.2.374

M. Chaussee, J. Liu, D. Stevens, and J. Ferretti, Genetic and Phenotypic Diversity among Isolates of Streptococcus pyogenes from Invasive Infections, Journal of Infectious Diseases, vol.173, issue.4, pp.901-908, 1996.
DOI : 10.1093/infdis/173.4.901

R. Aziz, M. Pabst, A. Jeng, R. Kansal, D. Low et al., Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties, Mol Microbiol. janv Res Microbiol. sept, vol.51149, issue.18, pp.539-548, 1998.

M. Yamaguchi, Y. Terao, S. Kawabata, K. Schmidt, K. Mann et al., Pleiotropic virulence factor -Streptococcus pyogenes fibronectin-binding proteins: Multiple role of S. pyogenes Fn-binding proteins Multiple binding of type 3 streptococcal M protein to human fibrinogen, albumin and fibronectin Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells, Cell Microbiol. avr FEMS Immunol Med Microbiol. août Infect Immun. oct, vol.15766, issue.4210, pp.503-511, 1993.

R. Willoughby, R. Greenberg, S. Rogers, T. Gooding, and M. Danchin, The Toxic Shock Syndrome and Streptococcal Pyrogenic Exotoxins, Annals of Internal Medicine, vol.98, issue.4, 1983.
DOI : 10.7326/0003-4819-98-4-559_1

M. Reglinski, S. Sriskandan, M. Kotb, A. Norrby-teglund, A. Mcgeer et al., The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner, Virulence. 1 janv Nat Med. déc PLoS Pathog. mai, vol.5810, issue.1125, pp.127-136, 2002.

S. Bhakdi, J. Tranum-jensen, and A. Sziegoleit, Mechanism of membrane damage by streptolysin-O, Infect Immun. janv, vol.47, issue.1, p.52, 1985.

J. Coleman, J. Benach, U. Ringdahl, J. Homeister, W. Fay et al., Use of the plasminogen activation system by microorganisms Plasminogen is a critical host pathogenicity factor for group A streptococcal infection, J Lab Clin Med. déc Science. 27 août, vol.134305, issue.65688, pp.1283-1286, 1999.

V. Brinkmann, U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann et al., Neutrophil Extracellular Traps Kill Bacteria, Science, vol.303, issue.5663, pp.1532-1535, 2004.
DOI : 10.1126/science.1092385

J. Cole, T. Barnett, V. Nizet, M. Walker, A. Sjöholm et al., Molecular insight into invasive group A streptococcal disease Protein SIC, a Novel Extracellular Protein of Streptococcus pyogenes Interfering with Complement Function Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes, 724? 736. 40. Åkesson P,1081? 1088. 41. Fernie-King, pp.390-398, 1996.

J. Ferretti, W. Mcshan, D. Ajdic, D. Savic, G. Savic et al., Complete genome sequence of an M1 strain of Streptococcus pyogenes, Proceedings of the National Academy of Sciences, vol.98, issue.8, pp.4658-4663, 2001.
DOI : 10.1073/pnas.071559398

J. Hacker, G. Blum-oehler, I. Mühldorfer, and H. Tschäpe, Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution, Molecular Microbiology, vol.23, issue.6, pp.1089-1097, 1997.
DOI : 10.1046/j.1365-2958.1997.3101672.x

S. Hollingshead, T. Readdy, D. Yung, D. Bessen, B. Kreikemeyer et al., Structural heterogeneity of the emm gene cluster in group A streptococci Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen?host interactions, Mol Microbiol. mai Trends Microbiol. mai, vol.811, issue.45, pp.707-717, 1993.

D. Bessen, C. Sotir, T. Readdy, S. Hollingshead, H. Courtney et al., Genetic Correlates of Throat and Skin Isolates of Group A Streptococci Relationship between Expression of the Family of M Proteins and Lipoteichoic Acid to Hydrophobicity and Biofilm Formation in Streptococcus pyogenes, ):e4166. 48. Beres SB, Musser JM. Contribution of Exogenous Genetic Elements to the Group A Streptococcus Metagenome. Ahmed N, éditeur. PLoS ONE. 29 août, pp.896-900, 1996.

J. Musser, V. Kapur, J. Szeto, X. Pan, D. Swanson et al., Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease, Infect Immun. mars, vol.63, issue.3, pp.994-1003, 1995.

J. Musser and R. Krause, 6 The revival of group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome Biomedical Research Reports [Internet] Academic Press, 1998.

I. Law, L. Matatolu, B. Beall, and J. Carapetis, Highly Successful Clone of Serotype M1 Group A Streptococcus Involved Multiple Horizontal Gene Transfer Events Global emm type distribution of group A streptococci: systematic review and implications for vaccine development, J Infect Dis. 9 janv Lancet Infect Dis. oct, vol.1929, issue.510, pp.611-616, 2005.

R. Aziz and M. Kotb, Rise and persistence of global M1T1 clone of Streptococcus pyogenes

R. Lancefield, . The, . Complex, . Streptococcus-haemolyticus:-i, . Demonstration et al., THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAeMOLYTICUS: I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAeMOLYTICUS., Journal of Experimental Medicine, vol.47, issue.1, p.91, 1928.
DOI : 10.1084/jem.47.1.91

F. Griffith, P. Geslin, P. Kriz-kuzemenska, V. Blanc, C. Devine et al., The Serological Classification of Streptococcus pyogenes Restricted association between biotypes and serotypes within group A streptococci, J Hyg (Lond). déc J Clin Microbiol. mai, vol.3432, issue.45, pp.1312-1317, 1934.

G. Rudd, C. White, H. Ward, . Studies, . Haemolytic et al., STUDIES ON HAEMOLYTIC STREPTOCOCCI FROM HUMAN SOURCES, Australian Journal of Experimental Biology and Medical Science, vol.17, issue.1, pp.25-34, 1939.
DOI : 10.1038/icb.1939.3

D. Johnson, Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor, Journal of Medical Microbiology, vol.55, issue.2, pp.157-164, 2006.
DOI : 10.1099/jmm.0.46224-0

K. Jones, O. Schneewind, J. Koomey, V. Fischetti, P. J. Md et al., Genetic diversity among the T-protein genes of group A streptococci, Molecular Microbiology, vol.5, issue.12, pp.149-162, 1965.
DOI : 10.1016/0378-1119(87)90365-9

D. Johnson, . World-health, and . Organization, Laboratory diagnosis of group A streptococcal infections. Geneva: World Health Organization, 1996.

G. Saravani and D. Martin, Opacity factor from group A streptococci is an apoproteinase, FEMS Microbiology Letters, vol.68, issue.1-2
DOI : 10.1111/j.1574-6968.1990.tb04118.x

A. Timmer, S. Kristian, V. Datta, A. Jeng, C. Gillen et al., Serum opacity factor promotes group A streptococcal epithelial cell invasion and virulence, Molecular Microbiology, vol.62, issue.1, pp.35-39, 1990.
DOI : 10.1016/0378-1097(91)90336-9

J. Widdowson, W. Maxted, D. Grant, S. Neal, B. Beall et al., The production of opacity in serum by group A streptococci and its relationship with the presence of M antigen International Quality Assurance Study for Characterization of Streptococcus pyogenes, J Gen Microbiol. J Clin Microbiol. 4 janv Facklam RF, vol.6145, issue.654, pp.343-531175, 1970.

R. Facklam, B. Beall, A. Efstratiou, V. Fischetti, D. Johnson et al., emm Typing and Validation of Provisional M Types for Group A Streptococci, Emerging Infectious Diseases, vol.5, issue.2, pp.247-253, 1999.
DOI : 10.3201/eid0502.990209

B. Beall, R. Facklam, T. Thompson, K. O-'brien, B. Beall et al., Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci, Epidemiology of Invasive Group A Streptococcus Disease in the United States, pp.268-276, 1995.

M. Enright, B. Spratt, A. Kalia, J. Cross, and D. Bessen, Multilocus Sequence Typing of Streptococcus pyogenes and the Relationships between emm Type and Clone, Infection and Immunity, vol.69, issue.4, pp.2416-2427, 2001.
DOI : 10.1128/IAI.69.4.2416-2427.2001

B. Luca-harari, J. Darenberg, S. Neal, T. Siljander, L. Strakova et al., Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing Clinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe, J Clin Microbiol. J Clin Microbiol. 21 janv, vol.3347, issue.734, pp.22331155-1165, 1995.

N. Hoe, K. Nakashima, D. Grigsby, X. Pan, S. Dou et al., Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus Invasive Group A Streptococcal Disease: Risk Factors for Adults Group A Streptococcus carriage among close contacts of patients with invasive infections, Emerg Infect Dis. avr J Clin Microbiol. déc Proc Natl Acad Sci Factor SH Emerg Infect Dis. août Am J Epidemiol, vol.535959149, issue.17689, pp.254-263, 1997.

A. Davies, H. Mcgeer, A. Schwartz, B. Green, K. Cann et al., Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis, 547? 554. 81. Stevens DL, Kaplan EL. Streptococcal Infections: Clinical Aspects, Microbiology, and Molecular Pathogenesis, pp.38-43113, 1996.

K. Robinson, G. Rothrock, Q. Phan, B. Sayler, K. Stefonek et al., Risk for severe group A streptococcal disease among patients' household contacts):443? 447. 84. CSHPF. Avis relatif a la conduite a tenir autour d'un ou de plusieurs cas, d'origine communautaire, d'infections invasives a Streptococcus pyogenes (ou streptocoques du groupe A), Emerg Infect Dis. avr, vol.9, issue.4, 2003.

M. Walker, J. Musser, R. Olsen, S. Shelburne, J. Musser et al., New understanding of the group A Streptococcus pathogenesis cycle Molecular mechanisms underlying group A streptococcal pathogenesis Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci, Commun Dis Public Health PHLS. déc Trends Microbiol. juill Cell Microbiol. janv Ann Med, vol.7151134, issue.882, pp.318-3251, 2002.

H. Kang, F. Coulibaly, F. Clow, T. Proft, E. Baker et al., Stabilizing Isopeptide Bonds Revealed in Gram-Positive Bacterial Pilus Structure Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2 Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques, 1625? 1628. 90. Sitkiewicz I, Proc Natl Acad Sci. 24 oct Proc Natl Acad Sci. 21 juin, pp.16009-16014, 2005.

S. Shelburne, D. Keith, M. Davenport, N. Horstmann, R. Brennan et al., Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis

A. Iafrate, L. Feuk, M. Rivera, M. Listewnik, P. Donahoe et al., Detection of largescale variation in the human genome Group A streptococci efficiently invade human respiratory epithelial cells, Nat Genet. sept Proc Natl Acad Sci, vol.3691, issue.925, pp.12115-12119, 1994.

B. Wang, S. Li, P. Southern, P. Cleary, R. Popa et al., Streptococcal modulation of cellular invasion via TGF-beta1 signaling Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. The Laryngoscope, Proc Natl Acad Sci U S A. 14 févr, pp.640-647, 1997.

U. Fluckiger, K. Jones, and V. Fischetti, Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells, Infect Immun. mars, vol.66, issue.3, pp.974-979, 1998.

L. Johansson, P. Thulin, D. Low, and A. Norrby?teglund, Deep Tissue Infections, Clinical Infectious Diseases, vol.51, issue.1, pp.58-65, 2010.
DOI : 10.1086/653116

T. Lamagni, J. Darenberg, B. Luca-harari, T. Siljander, A. Efstratiou et al., Epidemiology of Severe Streptococcus pyogenes Disease in Europe, Journal of Clinical Microbiology, vol.46, issue.7, pp.2359-2367, 2008.
DOI : 10.1128/JCM.00422-08

B. Lei, F. Deleo, S. Reid, J. Voyich, L. Magoun et al., Opsonophagocytosis-Inhibiting Mac Protein of Group A Streptococcus: Identification and Characteristics of Two Genetic Complexes, Infection and Immunity, vol.70, issue.12, pp.6880-6890, 2002.
DOI : 10.1128/IAI.70.12.6880-6890.2002

F. Tamura, R. Nakagawa, T. Akuta, S. Okamoto, S. Hamada et al., Proapoptotic Effect of Proteolytic Activation of Matrix Metalloproteinases by Streptococcus pyogenes Thiol Proteinase (Streptococcus Pyrogenic Exotoxin B), Infection and Immunity, vol.72, issue.8, pp.4836-4847, 2004.
DOI : 10.1128/IAI.72.8.4836-4847.2004

K. Laupland, H. Davies, D. Low, B. Schwartz, K. Green et al., Invasive Group A Streptococcal Disease in Children and Association With Varicella-Zoster Virus Infection, PEDIATRICS, vol.105, issue.5, p.60, 2000.
DOI : 10.1542/peds.105.5.e60

S. Factor, O. Levine, L. Harrison, M. Farley, A. Mcgeer et al., Risk Factors for Pediatric Invasive Group A Streptococcal Disease, Emerging Infectious Diseases, vol.11, issue.6, pp.1062-1066, 2005.
DOI : 10.3201/eid1107.040900

T. Lamagni, S. Neal, C. Keshishian, N. Alhaddad, R. George et al., Infections, United Kingdom, 2003???2004, Emerging Infectious Diseases, vol.14, issue.2, pp.202-209, 2003.
DOI : 10.3201/eid1402.070888

D. Stevens, Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis Off Publ Infect Dis Soc Am, oct, vol.21, issue.4, pp.977-980, 1995.

D. Stevens, Invasive Group A Streptococcus Infections, Clinical Infectious Diseases, vol.14, issue.1, pp.2-11, 1992.
DOI : 10.1093/clinids/14.1.2

C. Plainvert, A. Doloy, J. Loubinoux, A. Lepoutre, G. Collobert et al., Invasive group A streptococcal infections in adults, France (2006???2010), Clinical Microbiology and Infection, vol.18, issue.7, pp.702-710, 2012.
DOI : 10.1111/j.1469-0691.2011.03624.x

URL : https://hal.archives-ouvertes.fr/pasteur-01300168

A. Bisno and D. Stevens, Streptococcal Infections of Skin and Soft Tissues, New England Journal of Medicine, vol.334, issue.4, pp.240-246, 1996.
DOI : 10.1056/NEJM199601253340407

B. Gardiner, J. Wong, M. Yii, T. Buckenham, and T. Korman, Streptococcus pyogenes aortic aneurysm infection: forgotten but not gone, Infectious Disease Reports, vol.5, issue.2, p.11, 2013.
DOI : 10.4081/idr.2013.e11

T. Burkert and C. Watanakunakorn, Group A streptococcus endocarditis: Report of five cases and review of literature, Journal of Infection, vol.23, issue.3, pp.307-316, 1991.
DOI : 10.1016/0163-4453(91)93116-T

S. Sf-de and D. , Conférence de consensus : « Erysipèle et fasciite nécrosante : prise en charge, Méd Mal Infect. janv, vol.30, pp.241-246, 2000.

D. Stevens, A. Bisno, H. Chambers, E. Everett, P. Dellinger et al., Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections, Clinical Infectious Diseases, vol.41, issue.10, pp.1373-1406, 2005.
DOI : 10.1086/497143

S. Svane, Peracute spontaneous streptococcal myositis. A report on 2 fatal cases with review of literature, Acta Chir Scand, vol.137, issue.2, pp.155-163, 1971.

R. Baevsky, J. Ishida, and S. Lieberman, Group A beta-hemolytic streptococcal glossal necrotizing myositis--case report and review, MedGenMed Medscape Gen Med, vol.7, issue.2, p.8, 2005.

E. Yoder, J. Mendez, and R. Khatib, Spontaneous Gangrenous Myositis Induced by Streptococcus pyogenes: Case Report and Review of the Literature, Clinical Infectious Diseases, vol.9, issue.2, pp.382-385, 1987.
DOI : 10.1093/clinids/9.2.382

S. Shulman, Complications of streptococcal pharyngitis, Pediatr Infect Dis J. janv, vol.13, issue.1, pp.70-74, 1994.

M. Ryan, R. Kavanagh, P. Wall, and B. Hazleman, Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period, Rheumatology, vol.36, issue.3, pp.370-373, 1997.
DOI : 10.1093/rheumatology/36.3.370

E. Ibia, M. Imoisili, and A. Pikis, Group A ss-Hemolytic Streptococcal Osteomyelitis in Children, PEDIATRICS, vol.112, issue.1, pp.22-26, 2003.
DOI : 10.1542/peds.112.1.e22

I. Chuang, C. Van-beneden, B. Beall, and A. Schuchat, Population???Based Surveillance for Postpartum Invasive Group A Streptococcus Infections, 1995???2000, Clinical Infectious Diseases, vol.35, issue.6, pp.665-70, 1995.
DOI : 10.1086/342062

D. Mcintyre, An epidemic of Streptococcus pyogenes puerperal and postoperative sepsis with an unusual carrier site???the anus, American Journal of Obstetrics and Gynecology, vol.101, issue.3, pp.308-314, 1968.
DOI : 10.1016/0002-9378(68)90056-2

T. Mastro, T. Farley, J. Elliott, R. Facklam, J. Perks et al., An Outbreak of Surgical-Wound Infections Due to Group A Streptococcus Carried on the Scalp, New England Journal of Medicine, vol.323, issue.14, pp.968-972, 1990.
DOI : 10.1056/NEJM199010043231406

A. Viglionese, V. Nottebart, H. Bodman, and R. Platt, Recurrent group a streptococcal carriage in a health care worker associated with widely separated nosocomial outbreaks, The American Journal of Medicine, vol.91, issue.3, pp.329-333, 1991.
DOI : 10.1016/0002-9343(91)90391-A

P. Mead, J. Ribble, and T. Dillon, Group A streptococcal puerperal infection Report of an epidemic, Obstet Gynecol. oct, vol.32, issue.4, pp.460-464, 1968.

G. Gordon, B. Dale, and D. Lochhead, An outbreak of group A haemolytic streptococcal puerperal sepsis spread by the communal use of bidets, BJOG: An International Journal of Obstetrics and Gynaecology, vol.295, issue.5, pp.447-448, 1994.
DOI : 10.1016/0195-6701(89)90053-4

B. Claesson and U. Claesson, An outbreak of endometritis in a maternity unit caused by spread of group A streptococci from a showerhead, Journal of Hospital Infection, vol.6, issue.3, pp.304-311, 1985.
DOI : 10.1016/S0195-6701(85)80135-3

S. Roy, E. Kaplan, B. Rodriguez, J. Schreiber, R. Salata et al., A Family Cluster of Five Cases of Group A Streptococcal Pneumonia, PEDIATRICS, vol.112, issue.1, pp.61-65, 2003.
DOI : 10.1542/peds.112.1.e61

N. Kefalides, M. Pegg, N. Ohno, T. Poon-king, J. Zabriskie et al., Antibodies to basement membrane collagen and to laminin are present in sera from patients with poststreptococcal glomerulonephritis, Journal of Experimental Medicine, vol.163, issue.3, pp.588-602, 1986.
DOI : 10.1084/jem.163.3.588

G. Lee and M. Wessels, Changing Epidemiology of Acute Rheumatic Fever in the United States, Clinical Infectious Diseases, vol.42, issue.4, pp.448-450, 2006.
DOI : 10.1086/499817

L. Veasy, L. Tani, J. Daly, K. Korgenski, L. Miner et al., Temporal Association of the Appearance of Mucoid Strains of Streptococcus Pyogenes With a Continuing High Incidence of Rheumatic Fever in Utah, PEDIATRICS, vol.113, issue.3, pp.168-172, 2004.
DOI : 10.1542/peds.113.3.e168

L. Gordis, The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture, Circulation, vol.72, issue.6, pp.1155-1162, 1985.
DOI : 10.1161/01.CIR.72.6.1155

M. Wallace, P. Garst, T. Papadimos, and E. Oldfield, The Return of Acute Rheumatic Fever in Young Adults, JAMA: The Journal of the American Medical Association, vol.262, issue.18, pp.2557-2561, 1989.
DOI : 10.1001/jama.1989.03430180099037

J. Feuer and H. Spiera, Acute rheumatic fever in adults: a resurgence in the Hasidic Jewish community, J Rheumatol. févr, vol.24, issue.2, pp.337-340, 1997.

L. Veasy, S. Wiedmeier, G. Orsmond, H. Ruttenberg, M. Boucek et al., Resurgence of Acute Rheumatic Fever in the Intermountain Area of the United States, New England Journal of Medicine, vol.316, issue.8, pp.421-427, 1987.
DOI : 10.1056/NEJM198702193160801

L. Hello, S. Doloy, A. Baumann, F. Roques, N. Coudene et al., Clinical and Microbial Characteristics of Invasive Streptococcus pyogenes Disease in New Caledonia, a Region in Oceania with a High Incidence of Acute Rheumatic Fever, Journal of Clinical Microbiology, vol.48, issue.2, pp.526-530, 2010.
DOI : 10.1128/JCM.01205-09

H. Eagle, Experimental approach to the problem of treatment failure with penicillin, The American Journal of Medicine, vol.13, issue.4, pp.389-399, 1952.
DOI : 10.1016/0002-9343(52)90293-3

D. Stevens, S. Yan, and A. Bryant, Penicillin-Binding Protein Expression at Different Growth Stages Determines Penicillin Efficacy In Vitro and In Vivo: An Explanation for the Inoculum Effect, Journal of Infectious Diseases, vol.167, issue.6, pp.1401-1405, 1993.
DOI : 10.1093/infdis/167.6.1401

D. Stevens, A. Gibbons, R. Bergstrom, and V. Winn, The Eagle Effect Revisited: Efficacy of Clindamycin, Erythromycin, and Penicillin in the Treatment of Streptococcal Myositis, Journal of Infectious Diseases, vol.158, issue.1, pp.23-28, 1988.
DOI : 10.1093/infdis/158.1.23

D. Stevens, K. Maier, and J. Mitten, Effect of antibiotics on toxin production and viability of Clostridium perfringens., Antimicrobial Agents and Chemotherapy, vol.31, issue.2, pp.213-218, 1987.
DOI : 10.1128/AAC.31.2.213

M. Bergman, S. Huikko, M. Pihlajamäki, P. Laippala, E. Palva et al., Effect of Macrolide Consumption on Erythromycin Resistance in Streptococcus pyogenes in Finland in 1997-2001, Clinical Infectious Diseases, vol.38, issue.9, pp.1251-1256, 2004.
DOI : 10.1086/383309

J. Granizo, L. Aguilar, J. Casal, R. Dal-ré, and F. Baquero, Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997), Journal of Antimicrobial Chemotherapy, vol.46, issue.6, pp.959-964, 2000.
DOI : 10.1093/jac/46.6.959

R. Leclercq, Mechanisms of Resistance to Macrolides and Lincosamides: Nature of the Resistance Elements and Their Clinical Implications, Clinical Infectious Diseases, vol.34, issue.4, pp.482-492, 2002.
DOI : 10.1086/324626

M. Roberts, J. Sutcliffe, P. Courvalin, L. Jensen, J. Rood et al., Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants, Antimicrob Agents Chemother. 12 janv, vol.43, issue.12, pp.2823-2830, 1999.

R. Woodbury, K. Klammer, Y. Xiong, T. Bailiff, A. Glennen et al., Plasmid-Borne erm(T) from Invasive, Macrolide-Resistant Streptococcus pyogenes Strains, Antimicrobial Agents and Chemotherapy, vol.52, issue.3, pp.1140-1143, 2008.
DOI : 10.1128/AAC.01352-07

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2258515

J. Kataja, P. Huovinen, T. Group, and H. Seppälä, Erythromycin resistance genes in group A streptococci of different geographical origins, Journal of Antimicrobial Chemotherapy, vol.46, issue.5, pp.789-792, 2000.
DOI : 10.1093/jac/46.5.789

M. Hraoui, I. Boubaker, A. Doloy, S. Redjeb, and A. Bouvet, Isolates in Tunisia, Microbial Drug Resistance, vol.17, issue.3, pp.377-382, 2011.
DOI : 10.1089/mdr.2010.0160

S. Malhotra-kumar, C. Lammens, J. Piessens, and H. Goossens, Multiplex PCR for Simultaneous Detection of Macrolide and Tetracycline Resistance Determinants in Streptococci, Antimicrobial Agents and Chemotherapy, vol.49, issue.11, pp.4798-4800, 2005.
DOI : 10.1128/AAC.49.11.4798-4800.2005

T. Wood, M. Potter, and O. Jonasson, Streptococcal Toxic Shock-Like Syndrome, Annals of Surgery, vol.217, issue.2, p.109, 1993.
DOI : 10.1097/00000658-199302000-00003

Z. Mulla, P. Leaverton, and S. Wiersma, Invasive Group A Streptococcal Infections in Florida, Southern Medical Journal, vol.96, issue.10, pp.968-973, 2003.
DOI : 10.1097/01.SMJ.0000051060.95210.9A

J. Zimbelman, A. Palmer, and J. Todd, Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection, The Pediatric Infectious Disease Journal, vol.18, issue.12, pp.1096-1100, 1999.
DOI : 10.1097/00006454-199912000-00014

J. Riseman, W. Zamboni, C. A. Graham, D. Konrad, H. Ross et al., Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements, Surgery. nov, vol.108, issue.5, pp.847-850, 1990.

W. Barry, L. Hudgins, S. Donta, and E. Pesanti, Intravenous Immunoglobulin Therapy for Toxic Shock Syndrome, JAMA: The Journal of the American Medical Association, vol.267, issue.24, pp.3315-3316, 1992.
DOI : 10.1001/jama.1992.03480240077038

J. Yong, Necrotising fasciitis, The Lancet, vol.343, issue.8910, p.1427, 1994.
DOI : 10.1016/S0140-6736(94)92548-8

A. Linnér, J. Darenberg, J. Sjölin, B. Henriques-normark, and A. Norrby-teglund, Clinical Efficacy of Polyspecific Intravenous Immunoglobulin Therapy in Patients With Streptococcal Toxic Shock Syndrome: A Comparative Observational Study, Clinical Infectious Diseases, vol.59, issue.6, 2014.
DOI : 10.1093/cid/ciu449

A. Norrby-teglund, R. Kaul, D. Low, A. Mcgeer, D. Newton et al., Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production, J Immunol Baltim Md, vol.156, issue.8, pp.3057-3064, 1950.

H. Basma, A. Norrby-teglund, A. Mcgeer, D. Low, O. El-ahmedy et al., Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections, Infect Immun. mai, vol.66, issue.5, pp.2279-2283, 1998.

L. Valiquette, D. Low, R. Chow, and A. Mcgeer, A survey of physician's attitudes regarding management of severe group A streptococcal infections, Scandinavian Journal of Infectious Diseases, vol.19, issue.11-12, pp.11-12977, 2006.
DOI : 10.1097/00006454-199912000-00014

S. Mcneil, S. Halperin, J. Langley, B. Smith, A. Warren et al., Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers, Clinical Infectious Diseases, vol.41, issue.8, pp.1114-1122, 2005.
DOI : 10.1086/444458

M. Hu, M. Walls, S. Stroop, M. Reddish, B. Beall et al., Immunogenicity of a 26-Valent Group A Streptococcal Vaccine, Infection and Immunity, vol.70, issue.4, pp.2171-2177, 2002.
DOI : 10.1128/IAI.70.4.2171-2177.2002

O. Loughlin, R. Roberson, A. Cieslak, P. Lynfield, R. Gershman et al., The Epidemiology of Invasive Group A Streptococcal Infection and Potential Vaccine Implications: United States, 2000-2004, Clinical Infectious Diseases, vol.45, issue.7, pp.853-862, 2000.
DOI : 10.1086/521264

S. Shulman, R. Tanz, J. Dale, B. Beall, W. Kabat et al., Seven???Year Surveillance of North American Pediatric Group A Streptococcal Pharyngitis Isolates, Clinical Infectious Diseases, vol.49, issue.1, pp.78-84, 2009.
DOI : 10.1086/599344

D. Amicis, K. , F. De-barros, S. Alencar, R. Postól et al., Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes, Vaccine, vol.32, issue.32, 2014.
DOI : 10.1016/j.vaccine.2013.08.043

O. Grady, K. Kelpie, L. Andrews, R. Curtis, N. Nolan et al., The epidemiology of invasive group A streptococcal disease in Victoria, Australia, Med J Aust, vol.186, issue.11, 2007.

R. Norton, H. Smith, N. Wood, E. Siegbrecht, A. Ross et al., Invasive group A streptococcal disease in North Queensland, Indian J Med Res. mai, vol.119, 1996.

A. Lepoutre, A. Doloy, P. Bidet, A. Leblond, A. Perrocheau et al., Epidemiology of Invasive Streptococcus pyogenes Infections in France in 2007, Journal of Clinical Microbiology, vol.49, issue.12, pp.4094-4100, 2011.
DOI : 10.1128/JCM.00070-11

R. Kaul, A. Mcgeer, D. Low, K. Green, B. Schwartz et al., Population-Based Surveillance for Group A Streptococcal Necrotizing Fasciitis: Clinical Features, Prognostic Indicators, and Microbiologic Analysis of Seventy-Seven Cases, The American Journal of Medicine, vol.103, issue.1, pp.18-24, 1997.
DOI : 10.1016/S0002-9343(97)00160-5

D. Passaro, D. Smitht, E. Hett, A. Reingold, P. Daily et al., Invasive group A streptococcal infections in the San Francisco Bay area, 1989???99, Epidemiology and Infection, vol.129, issue.03, pp.471-478, 2002.
DOI : 10.1017/S0950268802007823

M. Fischer, K. Hedberg, P. Cardosi, B. Plikaytis, F. Hoesly et al., Tobacco smoke as a risk factor for meningococcal disease, The Pediatric Infectious Disease Journal, vol.16, issue.10, pp.979-983, 1997.
DOI : 10.1097/00006454-199710000-00015

J. Nuorti, J. Butler, M. Farley, L. Harrison, A. Mcgeer et al., Cigarette Smoking and Invasive Pneumococcal Disease, New England Journal of Medicine, vol.342, issue.10, pp.681-689, 2000.
DOI : 10.1056/NEJM200003093421002

D. Das, M. Baker, and K. Venugopal, Risk factors, microbiological findings and outcomes of necrotizing fasciitis in New Zealand: a retrospective chart review, BMC Infectious Diseases, vol.379, issue.1, p.348, 2012.
DOI : 10.1016/S0140-6736(11)61780-7

S. Lesko, O. Brien, K. Schwartz, B. Vezina, R. Mitchell et al., Invasive Group A Streptococcal Infection and Nonsteroidal Antiinflammatory Drug Use Among Children With Primary Varicella, PEDIATRICS, vol.107, issue.5, pp.1108-1115, 2001.
DOI : 10.1542/peds.107.5.1108

A. Krieg, L. Dizdar, P. Verde, and W. Knoefel, Predictors of mortality for necrotizing softtissue infections: a retrospective analysis of 64 cases, Langenbecks Arch Surg Dtsch Ges Chir. 11 janv, 2014.

J. Lin, L. Chang, C. Lai, H. Lin, and Y. Chen, Group A Streptococcal Necrotizing Fasciitis in the Emergency Department, The Journal of Emergency Medicine, vol.45, issue.5, pp.781-788, 2013.
DOI : 10.1016/j.jemermed.2013.05.046

S. Schwartz, E. Kightlinger, C. De-virgilio, M. De-virgilio, A. Kaji et al., Predictors of mortality and limb loss in necrotizing soft tissue infections, Am Surg. oct, vol.79, issue.10, pp.1102-1105, 2013.

C. Wong, L. Khin, K. Heng, K. Tan, and C. Low, The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: A tool for distinguishing necrotizing fasciitis from other soft tissue infections*, Critical Care Medicine, vol.32, issue.7, pp.1535-1541, 2004.
DOI : 10.1097/01.CCM.0000129486.35458.7D

A. Sharkawy, D. Low, R. Saginur, D. Gregson, B. Schwartz et al., Severe Group A Streptococcal Soft-Tissue Infections in Ontario: 1992-1996, Clinical Infectious Diseases, vol.34, issue.4, pp.454-460, 2002.
DOI : 10.1086/338466

S. Tyler, W. Johnson, J. Huang, F. Ashton, G. Wang et al., Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991, J Clin Microbiol. 12 janv, vol.30, issue.12, pp.3127-3131, 1992.

J. Darenberg, B. Henriques-normark, T. Lepp, K. Tegmark-wisell, A. Tegnell et al., Increased incidence of invasive group A streptococcal infections in Sweden, January 2012???February 2013, Eurosurveillance, vol.18, issue.14, p.20443, 2012.
DOI : 10.2807/1560-7917.ES2013.18.14.20443

M. Meehan, S. Murchan, S. Bergin, O. Flanagan, D. Cunney et al., Increased incidence of invasive group A streptococcal disease in Ireland, 2012 to 2013, Eurosurveillance, vol.18, issue.33, p.20556, 2013.
DOI : 10.2807/1560-7917.ES2013.18.33.20556

L. Olafsdottir, H. Erlendsdottir, J. Melo-cristino, D. Weinberger, M. Ramirez et al., Invasive infections due to Streptococcus pyogenes: seasonal variation of severity and clinical characteristics, Iceland Disponible sur, 1975.

D. Tasher, M. Stein, E. Simões, T. Shohat, M. Bromberg et al., Invasive Bacterial Infections in Relation to Influenza Outbreaks, 2006???2010, Clinical Infectious Diseases, vol.53, issue.12, pp.1199-1207, 2006.
DOI : 10.1093/cid/cir726

P. Lang, N. Samaras, D. Samaras, and R. Aspinall, How important is vitamin D in preventing infections? Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA, pp.1537-1553, 2013.

A. Friães, F. Pinto, C. Silva-costa, M. Ramirez, and J. Melo-cristino, Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance, BMC Microbiology, vol.12, issue.1, p.280, 2012.
DOI : 10.1186/1471-2105-13-87

B. Luca-harari, M. Straut, S. Cretoiu, M. Surdeanu, V. Ungureanu et al., Molecular characterization of invasive and non-invasive Streptococcus pyogenes isolates from Romania, Journal of Medical Microbiology, vol.57, issue.11, pp.1354-1363, 2008.
DOI : 10.1099/jmm.0.2008/001875-0

T. Siljander, O. Lyytikäinen, S. Vähäkuopus, M. Snellman, J. Jalava et al., Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland, European Journal of Clinical Microbiology & Infectious Diseases, vol.15, issue.10, pp.1229-1235, 2010.
DOI : 10.1007/s10096-010-0989-9

J. Darenberg, B. Luca-harari, A. Jasir, A. Sandgren, H. Pettersson et al., Molecular and Clinical Characteristics of Invasive Group A Streptococcal Infection in Sweden, Clinical Infectious Diseases, vol.45, issue.4, pp.450-458, 2007.
DOI : 10.1086/519936

S. Mehta, A. Mcgeer, D. Low, D. Hallett, D. Bowman et al., Morbidity and Mortality of Patients With Invasive Group A Streptococcal Infections Admitted to the ICU, Chest, vol.130, issue.6, pp.1679-1686, 2006.
DOI : 10.1016/S0012-3692(15)50887-8

G. Tyrrell, M. Lovgren, T. Jean, L. Hoang, D. Patrick et al., 59 Causing Invasive Disease in Canada, Clinical Infectious Diseases, vol.51, issue.11, pp.1290-1297, 2010.
DOI : 10.1086/657068